Acquisition by Perceptive Advisors Llc of 36000 shares of LianBio ADR subject to Rule 16b-3

LIANDelisted Stock  USD 2.18  0.05  2.24%   
About 61% of LianBio ADR's investor base is looking to short. The analysis of current outlook of investing in LianBio ADR suggests that many traders are alarmed regarding LianBio ADR's prospects. LianBio ADR's investing sentiment overview a quick insight into current market opportunities from investing in LianBio ADR. Many technical investors use LianBio ADR stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Lianbio director. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
LianBio insider trading alert for grant of stock option right to buy by Perceptive Advisors Llc, the corporate stakeholder, on 28th of April 2023. This event was filed by Lianbio with SEC on 2022-06-27. Statement of changes in beneficial ownership - SEC Form 4

LianBio ADR Fundamental Analysis

We analyze LianBio ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LianBio ADR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LianBio ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Ratio

Current Ratio Comparative Analysis

LianBio ADR is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

LianBio ADR Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LianBio ADR stock to make a market-neutral strategy. Peer analysis of LianBio ADR could also be used in its relative valuation, which is a method of valuing LianBio ADR by comparing valuation metrics with similar companies.

Peers

LianBio ADR Related Equities

TILInstil Bio   2.52   
0%
50.0%
SNSESensei Biotherapeutics   2.33   
0%
46.0%
TERNTerns Pharmaceuticals   2.12   
0%
42.0%
INZYInozyme Pharma   1.68   
0%
33.0%
LRMRLarimar Therapeutics   0.98   
0%
19.0%
ASMBAssembly Biosciences   0.20   
0%
4.0%
ELDNEledon Pharmaceuticals   0.45   
9.0%
0%
DAWNDay One   0.47   
9.0%
0%
HOOKHookipa Pharma   0.47   
9.0%
0%
NUVBNuvation Bio   0.76   
15.0%
0%
NXTCNextCure   0.92   
18.0%
0%
FENCFennec Pharmaceuticals   0.98   
19.0%
0%
ABOSAcumen Pharmaceuticals   1.93   
38.0%
0%
ACHLAchilles Therapeutics   2.94   
58.0%
0%
VRCAVerrica Pharmaceuticals   5.00   
100.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Consideration for investing in LianBio Stock

If you are still planning to invest in LianBio ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LianBio ADR's history and understand the potential risks before investing.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity